Aigremont, France

Eliane Rivalin

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • Aigremont, FR (2013)
  • Marnes la Coquette, FR (2020)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Eliane Rivalin: Innovator in Blood Analysis Technologies

Introduction

Eliane Rivalin is a notable inventor based in Aigremont, France. She has made significant contributions to the field of blood analysis, holding a total of 4 patents. Her work focuses on developing advanced systems and methods for blood typing, which are crucial for medical diagnostics.

Latest Patents

Rivalin's latest patents include innovative blood analysis systems and methods. These patents describe blood typing systems that utilize a substrate with immobilized binding agents. The method involves applying a sample to the substrate, where the binding agents can interact with substances in the sample. Unbound materials are then removed, allowing for the detection of the bound substances. This concurrent application and removal process enhances the efficiency of blood analysis.

Career Highlights

Throughout her career, Eliane Rivalin has worked with prominent companies in the biotechnology sector. Notably, she has been associated with Bio-Rad Innovations and Bio-Rad Europe GmbH. Her experience in these organizations has contributed to her expertise in developing innovative blood analysis technologies.

Collaborations

Eliane has collaborated with various professionals in her field, including her coworker Yves Raisin. Their joint efforts have further advanced the development of blood analysis systems.

Conclusion

Eliane Rivalin's contributions to blood analysis technologies demonstrate her commitment to innovation in the medical field. Her patents and career achievements reflect her significant impact on improving diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…